We serve Chemical Name:nitric acid,2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole CAS:118201-38-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:nitric acid,2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole
CAS.NO:118201-38-0
Synonyms:I06-1242;Tetrahydrozoline nitrate (JAN);UNII-8P9X484T3F;Narbel (TN)
Molecular Formula:C13H17N3O3
Molecular Weight:263.29200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:393.5ºC at 760 mmHg
Density:1.2 g/cm3
Index of Refraction:
PSA:90.44000
Exact Mass:263.12700
LogP:2.04810
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like I06-1242 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Narbel (TN) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tetrahydrozoline nitrate (JAN) Use and application,UNII-8P9X484T3F technical grade,usp/ep/jp grade.
Related News: FT was defined as any difficulty paying medical bills, high financial distress, cost-related medication nonadherence, food insecurity, and/or foregone/delayed care due to cost. nitric acid,2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole manufacturer Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality. nitric acid,2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole supplier Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality. nitric acid,2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole vendor ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. nitric acid,2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole factory Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.